The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Meyers Michael L. since 2018.
This trader's CIK number is 1664204.
At the time of last reporting, Meyers Michael L. was the SVP, Chief Medical Officer of Syndax Pharmaceuticals Inc. (stock ticker symbol SNDX).
Also see all insider trading activities at Syndax Pharmaceuticals Inc.
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2021 | SNDX | 0 | $0 | 0 | $0 | 5,900 | $51,743 |
| 2021 | SNDX | 500 | $7,730 | 0 | $0 | 0 | $0 |
| 2019 | SNDX | 1,104 | $5,409 | 0 | $0 | 0 | $0 |
| 2018 | SNDX | 200 | $958 | 0 | $0 | 0 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2021-12-30 | SNDX | Option Ex | 5,900 | 8.77 | 51,743 |
| 2021-04-26 | SNDX | Buy | 500 | 15.46 | 7,730 |
| 2019-03-21 | SNDX | Buy | 1,104 | 4.90 | 5,409 |
| 2018-10-30 | SNDX | Buy | 200 | 4.79 | 958 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Meyers Michael L. (SVP, Chief Medical Officer of Syndax Pharmaceuticals Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.